🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Marco Vignetti

Fondazione Gimema Onlus

ORCID: 0000-0003-1278-604X
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 5 papers. Top paper: Daunorubicin Versus Mitoxantrone Versus Idarubicin As Induction and Consolidation Chemotherapy for Adults With Acute Myeloid Leukemia: The EORTC and GIMEMA Groups Study AML-10.

188 citations

Marco Vignetti, Stefan Suciu, Roberto Stasi, Maria-Concetta Petti, Giovanna Meloni +15 more

121 citations

Katja Macijewski, Tamara Weiss, Ulrike Bacher, Susanne Schnittger, Wolfgang Kern +14 more

18 citations

Francesco Cottone, Betina R. Yanez, Vamsi Kota, Fausto Castagnetti, Giovanni Caocci +18 more

4 citations

Adriano Venditti, David Cella, Francesco Cottone, Anna Candoni, Lorella Melillo +14 more

22 citations

Francesco Cottone, Laura B. Oswald, David Cella, Andrea Patriarca, Pasquale Niscola +17 more